The Host

The midterm elections are months away, yet changes at the Department of Health and Human Services suggest the Trump administration is focusing on how to win on health care, which remains a top concern for voters. Facing growing concern about the administration’s actions on vaccines in particular, the Food and Drug Administration this week reversed course and said it would review a new mRNA-based flu vaccine after all.

And some top HHS officials are changing seats as the Senate prepares for the long-delayed confirmation hearing of President Donald Trump’s nominee for surgeon general, Casey Means.

This week’s panelists are Mary Agnes Carey of KFF Health News, Tami Luhby of CNN, Shefali Luthra of The 19th, and Lauren Weber of The Washington Post.

Among the takeaways from this week’s episode:

  • After a week of bad press, the FDA announced it would review Moderna’s application for a new flu vaccine. Yet the agency’s original refusal fits a pattern of agency decision-making based on individual officials’ views rather than set guidelines — and reinforces a precedent that’s problematic for drug development.
  • Those caught up in the latest HHS leadership shake-up include Jim O’Neill, who, as acting director of the Centers for Disease Control and Prevention, signed off on changes to the childhood vaccine schedule. His removal from that role comes as the White House is showing more interest in controlling health care messaging ahead of the midterms — and as polling shows Americans are increasingly concerned about federal vaccine policy.
  • Senators will hear from Means next week as they consider her nomination as surgeon general. Means, a key figure in the “Make America Healthy Again” movement, is expected to be asked about her medical credentials and past, problematic claims about medicine.
  • And while early numbers show that Affordable Care Act marketplace enrollment has not dipped as much as feared, Americans are still absorbing the rising cost of health care this year. The collapse of congressional efforts to reach a deal on renewing enhanced premium subsidies could be an issue for voters come November.

Plus, for “extra credit” the panelists suggest health policy stories they read this week that they think you should read, too:  

Mary Agnes Carey: Politico’s “Why Congress Failed To Reach an Obamacare Deal,” by Robert King and Simon J. Levien. 

Lauren Weber: NiemanLab’s “The Atlantic’s Elizabeth Bruenig on Her ‘Hypothetical,’ Heavily Reported Measles Essay,” by Laura Hazard Owen. 

Tami Luhby: The City’s “NewYork-Presbyterian Nurses Reject Contract by Overwhelming Margin,” by Claudia Irizarry Aponte and Ben Fractenberg. 

Shefali Luthra: NPR’s “Minneapolis Doctors Warn of Lasting Medical Effects, Even After ICE Agents Leave,” by Jasmine Garsd. 

Also mentioned in this week’s episode:


Click here to find all our podcasts.

And subscribe to “What the Health? From KFF Health News” on Apple Podcasts, Spotify, the NPR app, YouTube, Pocket Casts, or wherever you listen to podcasts.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Analysis reveals an additional mechanism behind statin therapy’s heart-related benefits in people with HIV

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize

Enhancing immune defenses: Researchers unveil the secrets of specialized T cells to conquer tumors

Our immune system has an ingenious trick up its sleeve. It remembers past foes, stopping potential sickness in its tracks through a phenomenon known as immunological memory. This is thanks

Recortes en servicios de idiomas generan temor a errores médicos, diagnósticos equivocados y muertes

SAN FRANCISCO, California — Organizaciones de salud sin fines de lucro e intérpretes médicos advierten que los recortes federales han eliminado docenas de puestos de trabajadores comunitarios en California, que